Contrary to what people might think, physicians do not go home and curl up with the New England Journal of Medicine and read randomized controlled trials. It’s just no one’s idea of a good time. We depend on our experts to synthesize medical literature and give us a clinically relevant synopsis. And that’s what reviews and commentaries are supposed to be. From the industry’s point of view, reviews and commentaries can be used to promote off label uses, new categories of diseases and completely ridiculous opinions.
Adriane Fugh-Berman gibt in einem Interview einen Einblick in Ghost-Writing, Publication-Strategy und Marketing der Pharmaindustrie.
